Izraelis - hebrajų - Ministry of Health

teva israel ltd - ciprofloxacin as hydrochloride - טבליה - ciprofloxacin as hydrochloride 500 mg - ciprofloxacin - ciprofloxacin - broad spectrum antibiotic for infections caused by ciprofloxacin sensitive pathogens: invasive infections of the external ear. treatment of acute pulmonary exacerbation of cystic fibrosis associated with p. aeruginosa infections in pediatric patients aged 5-17 years.

Izraelis - hebrajų - Ministry of Health

bioavenir ltd, israel - ciprofloxacin - תמיסה לאינפוזיה - ciprofloxacin 200 mg / 100 ml - ciprofloxacin - ciprofloxacin - broad spectrum antibiotic for infections caused by ciprofloxacin sensitive pathogens: treatment of acute pulmonary exacerbation of cystic fibrosis associated with p.aeroginosa infections in pediatric patients aged 5-17 years.

Izraelis - hebrajų - Ministry of Health

sanofi - aventis israel ltd - levofloxacin as hemihydrate - תמיסה לאינפוזיה - levofloxacin as hemihydrate 5 mg/ml - levofloxacin - levofloxacin - in adults for whom intravenous therapy is considered to be appropriate, tavanic solution for infusion is indicated for the treatment of the following infections when due to levofloxacin - susceptible micro-organisms: community- acquired pneumonia, complicated urinary tract infections including pyelonephritis, skin and soft tissue infections.

Izraelis - hebrajų - Ministry of Health

sanofi israel ltd - levofloxacin as hemihydrate - טבליות מצופות פילם - levofloxacin as hemihydrate 500 mg - levofloxacin - levofloxacin - in adults with infections of mild to moderate severity tavanic tablets are indicated for the treatment of the following infections when due to levofloxacin - susceptible micro-organisms: acute sinusitis, acute exacerbation of chronic bronchitis, community-acquired pneumonia, complicated urinary tract infections including pyelonephritis, skin and soft tissue infections.

Izraelis - hebrajų - Ministry of Health

unipharm ltd, israel - levofloxacin hemihydrate - טבליה - levofloxacin hemihydrate 500 mg - levofloxacin - levofloxacin - in adults with infections of mild to moderate severity for the treatment of the following infections when due to levofloxacin - susceptible micro-organisms: acute sinusitis, acute exacerbation of chronic bronchitis, community-acquired pneumonia, complicated urinary tract infections including pyelonephritis, skin and soft tissue infections.

Izraelis - hebrajų - Ministry of Health

teva pharmaceutical indust.ltd - levofloxacin hemihydrate 250 mg - tablets - levofloxacin - in adults with infections of mild to moderate severity levofloxacin teva tablets are indicated for the treatment of the following infections when due to levofloxacin - susceptible micro-organisms: - acute sinusitis. - acute exacerbation of chronic bronchitis. - community-acquired pneumonia. - complicated urinary tract infections including pyelonephritis. - skin and soft tissue infections.

Izraelis - hebrajų - Ministry of Health

teva pharmaceutical indust.ltd - levofloxacin hemihydrate 500 mg - tablets - levofloxacin - in adults with infections of mild to moderate severity levofloxacin teva tablets are indicated for the treatment of the following infections when due to levofloxacin - susceptible micro-organisms: - acute sinusitis. - acute exacerbation of chronic bronchitis. - community-acquired pneumonia. - complicated urinary tract infections including pyelonephritis. - skin and soft tissue infections.

Izraelis - hebrajų - Ministry of Health

bayer israel ltd - moxifloxacin as hydrochloride - טבליות מצופות פילם - moxifloxacin as hydrochloride 0.4 g - moxifloxacin - moxifloxacin - for the treatment of the following bacterial infections: respiratory infections: bronchitis: acute exacerbation of chronic bronchitis ; pneumonia: community acquired ; sinusitis: acute uncomplicated; community-acquired spontaneous and wound infections of the skin and skin structure.

Izraelis - hebrajų - Ministry of Health

bayer israel ltd - moxifloxacin as hydrochloride - טבליות מצופות פילם - moxifloxacin as hydrochloride 0.4 g - moxifloxacin - moxifloxacin - for the treatment of the following bacterial infections: respiratory infections: bronchitis: acute exacerbation of chronic bronchitis ; pneumonia: community acquired ; sinusitis: acute uncomplicated; community-acquired spontaneous and wound infections of the skin and skin structure.

Izraelis - hebrajų - Ministry of Health

bayer israel ltd - moxifloxacin as hydrochloride - תמיסה לאינפוזיה - moxifloxacin as hydrochloride 1.6 mg/ml - moxifloxacin - moxifloxacin - megaxin iv is indicated for the treatment of adults (> 18 years of age) with community acuired pneumonia caused by streptococcus pneumoniae, haemophilus influenzae, moraxella catarrhalis, staphylococcus aureus, klebsiella pneumoniae, mycoplasma pneumoniae or chlamydia pneumoniae and complicated skin and skin structure infections caused by methicillin susceptible staphylococus aureus, escherichia coli, klebsiella pneumoniae or enterobacter cloacae. appropriate culture and susceptibility tests should be performed before treatment in order to isolate and identify organisms causing infection and to determine their susceptibility to moxifloxacin. therapy with megaxin may be initiated before results of these tests are known; once results become available ,appropriate therapy should be continued.